Found 360 results
Author Keyword [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G. Mangili, Lorusso, D., Brown, J., Pfisterer, J., Massuger, L., Vaughan, M., Ngan, H. Y. S., Golfier, F., Sekharan, P. K., Charry, R. Cortés, Poveda, A. M., Kim, J. - W., Xiang, Y., Berkowtiz, R., and Seckl, M. J., Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S109-16, 2014.
T. Sugiyama, Kumagai, S., and Hatayama, S., [Treatments of epithelial ovarian cancer by histologic subtype], Gan To Kagaku Ryoho, vol. 36, pp. 187-92, 2009.
E. Greimel, Bjelic-Radisic, V., Pfisterer, J., Hilpert, F., Daghofer, F., Pujade-Lauraine, E., du Bois, A., Group, A. Gynaekolog, and de l'Ovaire, Gd'Investig, Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials, Support Care Cancer, vol. 19, pp. 1421-7, 2011.
S. De Placido, Scambia, G., Di Vagno, G., Naglieri, E., Lombardi, A. V., Biamonte, R., Marinaccio, M., Carteni, G., Manzione, L., Febbraro, A., De Matteis, A., Gasparini, G., Valerio, M. R., Danese, S., Perrone, F., Lauria, R., De Laurentiis, M., Greggi, S., Gallo, C., and Pignata, S., Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study, J Clin Oncol, vol. 22, pp. 2635-42, 2004.
D. K. Gaffney, Hashibe, M., Kepka, D., Maurer, K. A., and Werner, T. L., Too many women are dying from cervix cancer: Problems and solutions., Gynecol Oncol, 2018.
A. M. Poveda, Ten years of "Optimal Therapy in Advanced Ovarian Cancer. Update" meeting, Int J Gynecol Cancer, vol. 18 Suppl 1, pp. 67-70, 2008.
D. ' T. Anna, Signorelli, M., Benedetti-Panici, P., Maggioni, A., Fossati, R., Fruscio, R., Milani, R., Bocciolone, L., Buda, A., Mangioni, C., Scambia, G., Angioli, R., Campagnutta, E., Grassi, R., and Landoni, F., Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial, Br J Cancer, vol. 107, pp. 785-92, 2012.
P. B. Panici, Maggioni, A., Hacker, N., Landoni, F., Ackermann, S., Campagnutta, E., Tamussino, K., Winter, R., Pellegrino, A., Greggi, S., Angioli, R., Manci, N., Scambia, G., Dell'Anna, T., Fossati, R., Floriani, I., Rossi, R. S., Grassi, R., Favalli, G., Raspagliesi, F., Giannarelli, D., Martella, L., and Mangioni, C., Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial, J Natl Cancer Inst, vol. 97, pp. 560-6, 2005.
M. Leonard Friedlander, Stockler, M., O'Connell, R., Voysey, M., Oza, A. M., Gillies, K., Donovan, H., Martyn, J., Sjoquist, K. Marie, Butow, P., King, M. Trudy, and Group, S. Benefit St, Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the Gynecologic Cancer Intergroup symptom benefit study, Int J Gynecol Cancer, vol. 24, pp. 857-64, 2014.
R. Lindsay, Paul, J., Siddiqui, N. Ahmad, Davis, J., and Gaffney, D. K., Survey on the management of early cervical cancer among members of the GCIG., Int J Gynecol Cancer, vol. 22, no. 9, p. 1623, 2012.
B. Trimbos, Timmers, P., Pecorelli, S., Coens, C., Ven, K., van der Burg, M. E. L., and Casado, A., Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial., J Natl Cancer Inst, vol. 102, no. 13, pp. 982-7, 2010.
M. Mikami, Aoki, Y., Sakamoto, M., Shimada, M., Takeshima, N., Fujiwara, H., Matsumoto, T., Kita, T., Takizawa, K., Cervical, D. Committee, and Group, V. Cancer Jap, Surgical Principles for Managing Stage IB2, IIA2, and IIB Uterine Cervical Cancer (Bulky Tumors) in Japan: A Survey of the Japanese Gynecologic Oncology Group, Int J Gynecol Cancer, 2014.
B. You, Colomban, O., Heywood, M., Lee, C., Davy, M., Reed, N. Simon, Pignata, S., Varsellona, N., Emons, G., Rehman, K., Steffensen, K. Dahl, Reinthaller, A., Pujade-Lauraine, E., and Oza, A. M., The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study)., Gynecol Oncol, vol. 130, no. 2, p. 294, 2013.
Y. Watanabe, Aoki, D., Kitagawa, R., Takeuchi, S., Sagae, S., Sakuragi, N., Yaegashi, N., and Group, D. Committee, Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey, Gynecol Oncol, vol. 105, pp. 325-8, 2007.
A. du Bois, Kristensen, G. B., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I. B., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G., Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. Oliver, Merger, M., and Harter, P., Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial., Lancet Oncol, vol. 17, no. 1, p. 89, 2016.
D. Stark, Nankivell, M., Pujade-Lauraine, E., Kristensen, G. B., Elit, L., Stockler, M., Hilpert, F., Cervantes, A., Brown, J., Lanceley, A., Velikova, G., Sabate, E., Pfisterer, J., Carey, M. S., Beale, P., Qian, W., Swart, A. Marie, Oza, A. M., and Perren, T. J., Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial., Lancet Oncol, vol. 14, no. 3, p. 243, 2013.
A. M. Oza, Cook, A. D., Pfisterer, J., Embleton, A. C., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T. - W., Rustin, G. J. S., Joly, F., Mirza, M. R., Plante, M., Quinn, M., Poveda, A. M., Jayson, G. C., Stark, D., Swart, A. Marie, Farrelly, L., Kaplan, R. S., Parmar, M. K. B., and Perren, T. J., Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial., Lancet Oncol, vol. 16, no. 8, p. 936, 2015.
S. A. Welch, Hirte, H., Elit, L., Schilder, R. J., Wang, L., Macalpine, K., Wright, J. J., and Oza, A. M., Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium, Int J Gynecol Cancer, vol. 20, pp. 787-93, 2010.
M. L. Harrison, Hoskins, P., du Bois, A., Quinn, M., Rustin, G. J. S., Ledermann, J. A., Baron-Hay, S., and Friedlander, M. Leonard, Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study., Gynecol Oncol, vol. 100, no. 2, pp. 233-8, 2006.